ANI PHARMACEUTICALS, INC
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2014 | $106.5M | $139.8M | $169.0M |
| FY2015 | $113.4M | $160.1M | $154.7M |
| FY2016 | $0 | $169.6M | $27.4M |
| FY2017 | $69.9M | $174.8M | $31.1M |
| FY2018 | $67.3M | $197.3M | $43.0M |
| FY2019 | $175.8M | $212.8M | $62.3M |
| FY2020 | $172.4M | $195.7M | $7.9M |
| FY2021 | $286.5M | $333.9M | $100.3M |
| FY2022 | $285.7M | $313.7M | $48.2M |
| FY2023 | $284.8M | $432.7M | $221.1M |